Data provider

Wellcome Trust Sanger Institute Cancer Genome Project

Data provider ID Acronym URL
EGAO00000000007 WTSI CGP

This data provider is associated with 189 studies:

Study ID Title Type
EGAS00001000179 Renal Matched Pair Cell Line Exome Sequencing Cancer Genomics
EGAS00001000208 Cancer Genome Libraries Tests Whole Genome Sequencing
EGAS00001000088 Familial Thrombocytosis germline exome sequencing Cancer Genomics
EGAS00001000206 Cancer Exome Resequencing Cancer Genomics
EGAS00001000200 Acute Lymphoblastic Leukemia Exome sequencing 2 Cancer Genomics
EGAS00001000011 CLL cancer Sample Sequencing Cancer Genomics
EGAS00001000209 Acute Myeloid Leukemia Sequencing Cancer Genomics
EGAS00001000139 Splenic Marginal Zone Lymphoma with villous lymphocytes exome sequencing Cancer Genomics
EGAS00001000201 Acute Lymphoblastic Leukemia Exome sequencing Cancer Genomics
EGAS00001000027 TMD AMLK Exome Study Cancer Genomics
EGAS00001000037 Gastric and Esophageal tumour rearrangement screen Cancer Genomics
EGAS00001000218 CML Discovery Project Cancer Genomics
EGAS00001000009 SCLC Synthetic Genomics
EGAS00001000161 Triple Negative Breast Cancer sequencing Cancer Genomics
EGAS00001000033 1 Fanconi Anemia transformation to AML Cancer Genomics
EGAS00000000062 Complex Landscapes of Somatic Rearrangements in Human Breast Cancer Genomes Whole Genome Sequencing
EGAS00000000051 A small cell lung cancer genome reports complex tobacco exposure signatures Whole Genome Sequencing
EGAS00001000176 FRCC Exome sequencing Cancer Genomics
EGAS00001000193 ADCC Exome Sequencing Cancer Genomics
EGAS00001000087 Burden of Disease in Sarcoma Cancer Genomics
EGAS00001000188 Chordoma Exome Sequencing Cancer Genomics
EGAS00001000160 Matched Pair Cancer Cell line Whole Genomes Cancer Genomics
EGAS00001000006 Renal Cancer Exome Sequencing Cancer Genomics
EGAS00001000166 Breast Cancer Matched Pair Cell Line Whole Genomes Cancer Genomics
EGAS00001000211 Breast Cancer Exome Sequencing Cancer Genomics
EGAS00001000148 Lung Cancer Whole Genomes Cancer Genomics
EGAS00001000202 Glioma cell lines rearrangement screen Cancer Genomics
EGAS00001000005 Lung Rearrangement Study Cancer Genomics
EGAS00001000003 Cancer Single Cell Sequencing Other
EGAS00001000038 Chondrosarcoma Exome Cancer Genomics
EGAS00001000207 Breast Cancer Exome Resequencing Cancer Genomics
EGAS00001000103 Genomics of Colorectal Cancer Metastases Massively Parallel Sequencing of Matched Primary and Metastatic tumours to Identify a Metastatic Signature of Somatic Mutations MOSAIC Cancer Genomics
EGAS00001000205 Non Tumour Renal Cell Line Sequencing Cancer Genomics
EGAS00001000082 ALK inhibitors in the context of ALK dependent cancer cell lines Cancer Genomics
EGAS00001000014 CLL Cancer Whole Genome Sequencing Cancer Genomics
EGAS00001000081 CRLF2 sequencing project Exomes Cancer Genomics
EGAS00001000012 Various Cancer Fusion Gene Sequencing Cancer Genomics
EGAS00001000004 Multifocal Breast Project Cancer Genomics
EGAS00001000095 Renal Follow Up Series Cancer Genomics
EGAS00001000036 Integrative Oncogenomics of Multiple Myeloma Cancer Genomics
EGAS00001000035 Sequencing Acute Myeloid Leukaemia Synthetic Genomics
EGAS00001000178 Cell Line Sub Clone Rearrangement Screen Cancer Genomics
EGAS00001000031 Matched breast cancer fusion gene study Cancer Genomics
EGAS00001000140 Xenograft Sequencing Cancer Genomics
EGAS00001000030 ADCC Rearrangement Screen Cancer Genomics
EGAS00001000002 Breast Cancer Follow Up Series Cancer Genomics
EGAS00000000029 Massive Genomic Rearrangment Acquired in a Single Catastrophic Event During Cancer Development Whole Genome Sequencing
EGAS00001000080 CRLF2 sequencing project Cancer Genomics
EGAS00001000210 Breast Cancer Whole Genome Sequencing Cancer Genomics
EGAS00001000013 Osteosarcoma Sequencing Cancer Genomics
EGAS00001000220 Identifying Novel Fusion Genes in Myeloma Cancer Genomics
EGAS00001000094 PREDICT Cancer Genomics
EGAS00001000177 Meningioma Exome Cancer Genomics
EGAS00001000180 Mixed Leukemia Rearrangement Screen Cancer Genomics
EGAS00001000032 Kaposi sarcoma exome Cancer Genomics
EGAS00001000058 Acute Lymphoblastic Leukemia Sequencing Cancer Genomics
EGAS00000000064 The patterns and dynamics of genomic instability in metastatic pancreatic cancer Whole Genome Sequencing
EGAS00001000170 20 Matched Pair Breast Cancer Genomes Cancer Genomics
EGAS00001000147 Osteosarcoma Whole Genome Cancer Genomics
EGAS00001000034 MDSMPN Rearrangement Screen Cancer Genomics
EGAS00001000155 Matched Ovarian Cancer Sequencing Cancer Genomics
EGAS00001000230 RNAseq Pulldown Other
EGAS00001000466 FFPE CPA Accreditation Study Cancer Genomics
EGAS00001000261 Transcriptome Sequencing of Cancer Cell Lines Cancer Genomics
EGAS00001000278 Osteosarcoma Targeted Sequencing Study Cancer Genomics
EGAS00001000289 Lung Plasma rearrangement screen Cancer Genomics
EGAS00001000362 Ewings Sarcoma Rearrangement Screen Cancer Genomics
EGAS00001000360 Balanced Brain Tumour Whole Genome Sequencing Cancer Genomics
EGAS00001000282 Meningioma Targeted Sequencing Study Cancer Genomics
EGAS00001000408 Targeted sequencing of genes recurrently mutated in AML Cancer Genomics
EGAS00001000243 Integrative Oncogenomics of multiple myeloma Other
EGAS00001000390 Targeted gene fusion sequencing Fus seq in mesothelioma Cancer Genomics
EGAS00001000173 Testing the feasibility of genome scale sequencing in routinely collected FFPE cancer specimens versus matched fresh frozen samples Cancer Genomics
EGAS00001000292 Molecular characterization of invasive lobular carcinoma Cancer Genomics
EGAS00001000297 Feasibility of targeted capture sequencing in routinely collected FFPE cancer specimens Cancer Genomics
EGAS00001000280 Chordoma Targeted Sequencing Study Cancer Genomics
EGAS00001000301 Cancer Genome Project Exome Sequencing Other
EGAS00001000354 Primary Lung Cancer whole genome study Cancer Genomics
EGAS00001000216 Melanoma TIL Study Exomes Other
EGAS00001000174 Balanced Ependymoma Cancer Genomics
EGAS00001000214 Test of PCR library method on whole genmoe samples Cancer Genomics
EGAS00001000275 AML targeted resequencing study Cancer Genomics
EGAS00001000293 Evaluation of size selection on cancer specific sequencing libraries Cancer Genomics
EGAS00001000181 Chondrosarcoma Validation Study Cancer Genomics
EGAS00001000300 Breast cancer sequential sampling study Cancer Genomics
EGAS00001000332 Helleday HRAS Project Cancer Genomics
EGAS00001000406 Myeloproliferative Neoplasms MPN Targeted Gene Screen Cancer Genomics
EGAS00001000233 Pulldown cytosine deaminases Cancer Genomics
EGAS00001000244 Integrative Oncogenomics of multiple myeloma Other
EGAS00001000276 Genetic mechanisms of resistance to chemotherapy in breast cancer Other
EGAS00001000428 Neoadjuvant Breast Cancer Validations Cancer Genomics
EGAS00001000165 Monotherapy Breast Cancer Cancer Genomics
EGAS00001000353 The genomic architecture of mesothelioma Cancer Genomics
EGAS00001000420 Breast Cancer FRT RNA seq Cancer Genomics
EGAS00001000250 Poikiloderma syndrome RNAseq Cancer Genomics
EGAS00001000419 Ewings Sarcoma RNA seq drug sensitivity Cancer Genomics
EGAS00001000267 RNAseq of patients with Ewings sarcoma Cancer Genomics
EGAS00001000251 Melanoma Til Study RNAseq Cancer Genomics
EGAS00001000434 Matched Pair Cell Line Tumour RNAseq Cancer Genomics
EGAS00001000310 RNA sequencing Other
EGAS00001000551 Discovery of resistance mechanisms to the BRAF inhibitor vemurafenib in metastatic BRAF mutant melanoma Other
EGAS00001000606 Pseudogene RNAseq Cancer Genomics
EGAS00001000570 Targeted sequencing of genes recurrently mutated in AML part2 Cancer Genomics
EGAS00001000596 Breast Cancer Sequential Sampling Targeted Capture Cancer Genomics
EGAS00001000587 Epi Tax targeted sequencing Cancer Genomics
EGAS00001000603 Use of Deep Sequencing to Dectect Clonal Mutations In Sun Exposed Skin Epidermis PART2 Cancer Genomics
EGAS00001000470 CMF RNA sequencing Cancer Genomics
EGAS00001000264 Shwachman Diamond syndrome SDS Exome sequencing Other
EGAS00001000663 MPN mutation order followup Cancer Genomics
EGAS00001000655 Combination therapies for personalized cancer medicine Cancer Genomics
EGAS00001000692 FFPE CPA Accreditation Study Part 2 Cancer Genomics
EGAS00001000649 GEL WGS Comparison Cancer Genomics
EGAS00001000648 FinHer Breast Cancer Study Cancer Genomics
EGAS00001000616 BIG MS Pilot Cancer Genomics
EGAS00001000651 Mutational Signatures of relapse in rectal cancer FFPE samples in the CR07 clinical trial Cancer Genomics
EGAS00001000902 Metastatic Breast Cancer Whole Genome Cancer Genomics
EGAS00001000612 PLCRC study Cancer Genomics
EGAS00001000613 Mosaic Colorectal Metastasis Cancer Genomics
EGAS00001000891 Multisite Primary Breast Cancer Cancer Genomics
EGAS00001000407 Characterization of individual foci of multicentric multifocal breast cancer using targeted next generation sequencing Cancer Genomics
EGAS00001000436 Lung Multi site Targeted Sequence Capture Cancer Genomics
EGAS00001000704 Metastatic breast cancer targeted gene screen Cancer Genomics
EGAS00001000743 Myeloma Follow up Pilot Cancer Genomics
EGAS00001000751 Transposome Bisulfite Sequencing Cancer Genomics
EGAS00001000968 Origins and functional consequence of somatic mitochondrial DNA mutations Other
EGAS00001000840 Spatial and temporal diversity in genomic instability processes define early stage lung cancer evolution. Other
EGAS00001000978 Cancer Cell Line Exome Sequencing Cancer Genomics
EGAS00001000763 Expressed fusion transcripts in rare bone tumours Cancer Genomics
EGAS00001000468 Harnessing transposons for drug resistance gene discovery in cancer Cancer Genomics
EGAS00001000813 RNAseq Discovery of resistance mechanisms to the BRAF inhibitor vemurafenib in metastatic BRAF mutant melanoma Cancer Genomics
EGAS00001000812 Discovery of resistance mechanisms to the BRAF inhibitor vemurafenib in metastatic BRAF mutant melanoma Cancer Genomics
EGAS00001000333 Multiple Malignancy Familial Comparison Cancer Genomics
EGAS00001000533 Chondromyxoid fibroma Cancer Genomics
EGAS00001000260 Targeted Pulldown Validation of mutations found in whole genome sequencing Cancer Genomics
EGAS00001000515 Use of Deep Sequencing to Dectect Clonal Mutations In Sun Exposed Skin Epidermis Cancer Genomics
EGAS00001000728 SPECTA NGS Screening Program for Efficient Clinical Trial Access Cancer Genomics
EGAS00001000860 Use of deep sequencing to detect clonal mutations in sun exposed human epidermis whole genome Cancer Genomics
EGAS00001000836 FFPE Normal Panel V3 Cancer Panel Cancer Genomics
EGAS00001000880 Myeloma Targeted Follow up Study Cancer Genomics
EGAS00001000979 Pulldown DNA methylation study v2 Cancer Genomics
EGAS00001000765 MPN TGS2 Follow up PT1 Vori other Cancer Genomics
EGAS00001000879 Prognostic factors in prostate cancer deep sequencing pilot project TAPG Cancer Genomics
EGAS00001000830 Mesothelioma Whole Genomes Cancer Genomics
EGAS00001000851 Primary angiosarcoma Whole Genome Sequencing Cancer Genomics
EGAS00001000859 Anaplastic Meningioma WGS X10 Cancer Genomics
EGAS00001000837 Lung Progression versus Regression Whole Genome Sequencing Cancer Genomics
EGAS00001001129 IBDCA Edinburgh Other
EGAS00001000934 PREDICT Whole Genomes Cancer Genomics
EGAS00001000946 Mechanisms of patient response to Dabrafenib in Melanoma Cancer Genomics
EGAS00001001060 CRISPR screen M14 NCI H3122 Cancer Genomics
EGAS00001000195 Breast Cancer Somatic Genetics Study Cancer Genomics
EGAS00001001095 NGS based viability screening using haploid cell line Cancer Genomics
EGAS00001001155 Anaplastic Meningioma V3 cancer gene panel Cancer Genomics
EGAS00001000203 ChIP sequencing in Cancer Cell Lines Cancer Genomics
EGAS00001000857 Deep sequencing of melanoma for driver mutations Cancer Genomics
EGAS00001000872 Chugai colorectal organoid sequencing Cancer Genomics
EGAS00001000881 Colorectal organoids and tumour tissue Cancer Genomics
EGAS00001000402 Feasibility of targeted capture sequencing in FFPE cancer specimens 2 Cancer Genomics
EGAS00001000435 Single Cell Targeted Sequence Capture Cancer Genomics
EGAS00001000955 EBV AID project Cancer Genomics
EGAS00001000985 RNAseq Colorectal organoids and tumoroids Cancer Genomics
EGAS00001001218 Validation for human early embryonic substitutions Cancer Genomics
EGAS00001001059 Cell lines with telomere fusion induced rearrangements Cancer Genomics
EGAS00001001158 Leeds Melanoma Cohort Cancer Genomics
EGAS00001001304 Resistance to MAPK inhibitor induces internal duplication in BRAF Other
EGAS00001001171 Mutational Analysis of Colorectal PDX models Cancer Genomics
EGAS00001000858 Integrative genome profiling in AML Cancer Genomics
EGAS00001001261 Colorectal Adenoma Gene Screen Cancer Genomics
EGAS00001001382 OCCAMS Oesophageal Cancer Organoids 1 Cancer Genomics
EGAS00001001299 Multiple Myeloma Diagnosis to Relapse study samples Cancer Genomics
EGAS00001001743 ENU CCK 81 cetuximab pilot project Cancer Genomics
EGAS00001001744 ENU NCI H508 cetuximab fixed concentration project Cancer Genomics
EGAS00001001777 ENU LS 411N TripleTherapy Cancer Genomics
EGAS00001001195 ICGC Breast Cancer Project Other
EGAS00001001778 ENU HT 29 BRAF Triple Therapy Clones Cancer Genomics
EGAS00001001745 ENU NCI H508 Cetuximab SecondRound Cancer Genomics
EGAS00001001173 Reference DNA standards for GCLP pipeline Cancer Genomics
EGAS00001001520 BAP1 sequence of uveal melanoma cell lines Cancer Genomics
EGAS00001001573 The genetic evolution of precursor lesions in pancreatic cancer Cancer Genomics
EGAS00001001614 Melanoma C32 ENU resistance to Combination Therapy Cancer Genomics
EGAS00001000266 Exome sequencing of patients with Ewings sarcoma Other
EGAS00001001968 Metastatic Breast Cancer Validation Cancer Genomics
EGAS00001000092 Triple Negative Breast Cancer Whole Genomes Cancer Genomics
EGAS00001001967 FFPE whole genome pilot Cancer Genomics
EGAS00001001971 In Situ Transcription whole genome sequencing Cancer Genomics
EGAS00001001972 Breast Heterogeneity Validation Cancer Genomics
EGAS00001000869 Colorectal organoids and tumoroids pulldown Cancer Genomics
EGAS00001000277 Chondrosarcoma Targeted Sequencing Study Cancer Genomics
EGAS00001000172 BRAF and MEK resistant cell line clones Cancer Genomics